Cluster.K=2.ConsensusMatrix

NIAID Data Ecosystem2026-05-01 收录

三阴性乳腺癌亚型分类

肿瘤干性评估

数据链接：

https://figshare.com/articles/dataset/Cluster_K_2_ConsensusMatrix/24432925 数据链接链接失效反馈

官方服务：

资源简介：

127 patients with TNBC were classified into two stemness subgroups, utilized an unsupervised consensus clustering method to construct a novel classification of TNBC in the TCGA cohort to analyze the association between mRNAsi and TNBC subtypes.

创建时间：

2023-11-17

Tumor Stemness Score to Estimate Epithelial-to-Mesenchymal Transition (EMT) and Cancer Stem Cells (CSCs) Characterization and to Predict the Prognosis and Immunotherapy Response in Bladder Urothelial Carcinoma

肿瘤干性评估

膀胱癌免疫治疗反应预测

Background: The relationships between cancer stem cells (CSCs), epithelial-to-mesenchymal transition (EMT), and the tumor microenvironment (TME) in bladder urothelial carcinoma (BLCA) remain unclear.

NIAID Data Ecosystem50

S1_Paired Data 1.xlsx

肿瘤干性评估

癌症转移临床病理

S1_Paired Data.xlsx is a database in excel format paired with the TCGA database patient ID (TCGAlong.id). Each ID contains the Stemness of normal tissue [EREG-mRNAsi(Normal)] and the Stemness of tumor

NIAID Data Ecosystem30

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features

三阴性乳腺癌亚型分类

预后风险分层

Introduction Overexpression of the androgen receptor (AR) characterizes a distinct molecular subset of triple negative breast carcinomas (TNBC). The role of AR as a prognostic/predictive biomarker in

NIAID Data Ecosystem30

RNAseq of a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification. RNAseq of a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

三阴性乳腺癌亚型分类

RNA转录组分析

Our aims is correlate the data and classification of the subtype breast cancer obtained with the Pam50 assay with the data obtained from the analysis of the same patients RNAseq Overall design: Total

NIAID Data Ecosystem40

Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies

三阴性乳腺癌亚型分类

药物靶点发现

Triple-negative breast cancer (TNBC) is the most heterogeneous and aggressive subtype of breast carcinoma, defined by the absence of clinical biomarkers and the lack of targeted therapies. Despite num

NIAID Data Ecosystem30

Cluster.K=2.ConsensusMatrix

资源简介：

相关数据集